fludarabine has been researched along with Drug Hypersensitivity in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
AlRiyami, L; Grunebaum, E; Hook, R; Rao, H; Schechter, T; Wall, DA; Xu, M | 1 |
Chua, KYL; Holmes, NE; Meher-Homji, Z; Phillips, EJ; Seymour, JF; Siderov, J; Slavin, MA; Tam, CS; Trubiano, JA | 1 |
Bosanquet, AG; Chapman, CS; Hutchinson, RM; Parker, AN | 1 |
3 other study(ies) available for fludarabine and Drug Hypersensitivity
Article | Year |
---|---|
Successful desensitization protocol for a patient with fludarabine anaphylaxis during hematopoietic transplantation.
Topics: Anaphylaxis; Desensitization, Immunologic; Drug Hypersensitivity; Hematopoietic Stem Cell Transplantation; Humans; Vidarabine | 2022 |
High prevalence of antibiotic allergies in cladribine-treated patients with hairy cell leukemia - lessons for immunopathogenesis and prescribing.
Topics: Adult; Aged; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Australia; Case-Control Studies; Cladribine; Drug Hypersensitivity; Female; Follow-Up Studies; Humans; Leukemia, Hairy Cell; Male; Middle Aged; Prevalence; Prognosis; Retrospective Studies; Survival Rate; Vidarabine | 2019 |
Effective treatment of relapsed acute myeloid leukaemia with drugs chosen by DiSC assay.
Topics: Acute Disease; Antineoplastic Agents; Cytotoxicity Tests, Immunologic; Drug Hypersensitivity; Etoposide; Female; Humans; Leukemia, Myeloid; Middle Aged; Mitoxantrone; Recurrence; Vidarabine | 1992 |